Research progress on targeted drugs for vascular malformations
Vascular malformations, which mainly occur in the head and neck region, are a group of congenital disorders that cannot involute and dilate gradually as patients grow. Traditional therapeutic strategies for vascular malformations include laser therapy, sclerotherapy, interventional embolization, sur...
Main Authors: | SHEN Yuchen, WANG Deming, FAN Xindong |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Department of Journal of Prevention and Treatment for Stomatological Diseases
2023-04-01
|
Series: | 口腔疾病防治 |
Subjects: | |
Online Access: | http://www.kqjbfz.com/CN/10.12016/j.issn.2096-1456.2023.04.010 |
Similar Items
-
Treatment of voluminous and complicated superficial slow-flow vascular malformations with sirolimus (PERFORMUS): protocol for a multicenter phase 2 trial with a randomized observational-phase design
by: Annabel Maruani, et al.
Published: (2018-06-01) -
Blocking Mammalian Target of Rapamycin (mTOR) Alleviates Neuropathic Pain Induced by Chemotherapeutic Bortezomib
by: Zongsheng Duan, et al.
Published: (2018-07-01) -
Combination of mTOR and MAPK Inhibitors—A Potential Way to Treat Renal Cell Carcinoma
by: Ashutosh Chauhan, et al.
Published: (2016-10-01) -
Topical sirolimus 0.1% for treating cutaneous microcystic lymphatic malformations in children and adults (TOPICAL): protocol for a multicenter phase 2, within-person, randomized, double-blind, vehicle-controlled clinical trial
by: Sophie Leducq, et al.
Published: (2019-12-01) -
Sirt1 decreased adipose inflammation by interacting with Akt2 and inhibiting mTOR/S6K1 pathway in mice[S]
by: Zhenjiang Liu, et al.
Published: (2016-08-01)